Get the Weekly Intelligence Brief — top committee picks every Sunday.

DNTH vs HSIC

Dianthus Therapeutics, Inc. vs Henry Schein — AI-powered side-by-side comparison
DNTH
Dianthus Therapeutics, Inc.
54
Watch
VS
HSIC
Henry Schein
67
Buy
MetricDNTHHSIC
AI Score 54 67
Price $108.40 $89.16
P/E Ratio -834.54× 25.77×
ROE -32.9% 12.3%
Revenue Growth YoY
Gross Margin 96.0% 30.3%
Debt / Equity 0.00× 1.21×
Dividend Yield 0.0% 0.0%
RSI (14) 52.5 59.4
Beta 0.082 0.808
Expected Upside +0.8%

AI Committee View

Current Innellis committee reasoning for DNTH versus HSIC.
HSIC leads by 13 points.

HSIC scores 67/100 (Buy) versus DNTH at 54/100 (Watch).

DNTH Committee View
50% agreement
6 analysts

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Growth Analyst remains cautious — revenue declining -60.8% yoy -- this is not a growth story right now. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • Price structure making higher highs and higher lows — Technical
  • Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
  • Low leverage (debt-to-equity 0.00) -- balance sheet can absorb a shock — Risk
Bear Case
  • ROE of only -22.5% -- cheap may mean cheap for a reason — Value
  • Revenue declining -60.8% YoY -- this is not a growth story right now — Growth
  • MACD histogram negative -- bearish momentum — Technical
HSIC Committee View
75% agreement
4 analysts

The primary driver is vix regime is low -- calm backdrop supports risk-taking. The main limiting factor is growth rate is decelerating quarter over quarter -- the trend line matters more than the level. The committee is constructive but not yet at full conviction.

Bull Case
  • 4 consecutive earnings beats -- consistent execution — Growth
  • Price structure making higher highs and higher lows — Technical
  • MACD histogram positive -- bullish momentum — Technical
Bear Case
  • Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
DNTH Full Analysis HSIC Full Analysis